NCT01102465

Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg /25 mg Tablet Under Fed Conditions

A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide Tablets 100 mg/25 mg Under Fed Conditions

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 25 (actual)
• Sponsor: Roxane Laboratories · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The objective of this study was to prove the bioequivalence of losartan potassium/hydrochlorothiazide 100/25 mg tablet under fed conditions.

Conditions

• Hypertension

Interventions

Type	Name	Description
DRUG	losartan potassium hydrochlorothiazide	100 mg / 25 mg tablet

Timeline

• Start date: 2005-02-01
• Primary completion: 2005-03-01
• Completion: 2005-03-01
• First posted: 2010-04-13
• Last updated: 2018-01-23

Locations

1 site across 1 country: United States